Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial
免疫检查点抑制剂治疗与靶向治疗治疗晚期肾细胞癌的无治疗生存期:CheckMate 214试验的42个月结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-2283
Regan, Meredith M; Jegede, Opeyemi A; Mantia, Charlene M; Powles, Thomas; Werner, Lillian; Motzer, Robert J; Tannir, Nizar M; Lee, Chung-Han; Tomita, Yoshihiko; Voss, Martin H; Plimack, Elizabeth R; Choueiri, Toni K; Rini, Brian I; Hammers, Hans J; Escudier, Bernard; Albiges, Laurence; Huo, Stephen; Del Tejo, Viviana; Stwalley, Brian; Atkins, Michael B; McDermott, David F
Checkpoint
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌